105 related articles for article (PubMed ID: 29501043)
21. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
22. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.
Wang S; Li J; Xie J; Liu F; Duan Y; Wu Y; Huang S; He X; Wang Z; Wu X
Oncogene; 2018 Jul; 37(30):4164-4180. PubMed ID: 29706653
[TBL] [Abstract][Full Text] [Related]
23. PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway.
Zheng HY; Shen FJ; Tong YQ; Li Y
Curr Med Sci; 2018 Feb; 38(1):115-123. PubMed ID: 30074160
[TBL] [Abstract][Full Text] [Related]
24. Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer.
Song Y; Guo Q; Gao S; Hua K
Biochem Biophys Res Commun; 2018 Apr; 498(3):686-692. PubMed ID: 29524410
[TBL] [Abstract][Full Text] [Related]
25. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
26. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
Wang F; Shan S; Huo Y; Xie Z; Fang Y; Qi Z; Chen F; Li Y; Sun B
Int J Biochem Cell Biol; 2018 Jun; 99():91-99. PubMed ID: 29627439
[TBL] [Abstract][Full Text] [Related]
27. Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.
Deshpande R; Mansara P; Kaul-Ghanekar R
Tumour Biol; 2016 Mar; 37(3):3295-305. PubMed ID: 26440049
[TBL] [Abstract][Full Text] [Related]
28. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
29. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
Liu Z; Teng L; Gao L; Wang H; Su Y; Li J
Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728
[TBL] [Abstract][Full Text] [Related]
30. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
31. De-regulation of the RBBP6 isoform 3/DWNN in human cancers.
Mbita Z; Meyer M; Skepu A; Hosie M; Rees J; Dlamini Z
Mol Cell Biochem; 2012 Mar; 362(1-2):249-62. PubMed ID: 22139301
[TBL] [Abstract][Full Text] [Related]
32. RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression.
Dlamini Z; Ledwaba T; Hull R; Naicker S; Mbita Z
Biomark Cancer; 2019; 11():1179299X19829149. PubMed ID: 30886526
[TBL] [Abstract][Full Text] [Related]
33. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
Huang W; Zhu S; Liu Q; Li C; Li L
Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
[TBL] [Abstract][Full Text] [Related]
34. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract][Full Text] [Related]
35. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
37. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
Xiao C; Wang Y; Zheng M; Chen J; Song G; Zhou Z; Zhou C; Sun X; Zhong L; Ding E; Zhang Y; Yang L; Wu G; Xu S; Zhang H; Wang X
Cancer Sci; 2018 Apr; 109(4):1075-1087. PubMed ID: 29369481
[TBL] [Abstract][Full Text] [Related]
38. KLF14 activates the JNK-signaling pathway to induce S-phase arrest in cervical cancer cells.
Du Y; Ye H; Lin M; Cao L
Front Immunol; 2023; 14():1267950. PubMed ID: 38143751
[TBL] [Abstract][Full Text] [Related]
39. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
[TBL] [Abstract][Full Text] [Related]
40. WNT6 promotes the migration and differentiation of human dental pulp cells partly through c-Jun N-terminal kinase signaling pathway.
Li R; Wang C; Tong J; Su Y; Lin Y; Zhou X; Ye L
J Endod; 2014 Jul; 40(7):943-8. PubMed ID: 24935540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
